Cargando…

Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients

OBJECTIVE: The primary purpose of this study was to investigate the correlation between single nucleotide polymorphisms (SNPs) of ATP binding cassette superfamily G member 2 (ABCG2) and outcome of tyrosine kinase inhibitions (TKIs) therapy in Chinese advanced non-small-cell lung cancer (NSCLC) patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xueqin, Chen, Dadong, Yang, Shaoyu, Ma, Ruobing, Pan, Yuelong, Li, Xin, Ma, Shenglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425882/ https://www.ncbi.nlm.nih.gov/pubmed/25960692 http://dx.doi.org/10.1186/s12935-015-0191-3

Ejemplares similares

Rechallenge with gefitinib following severe drug-induced hepatotoxicity in a patient with advanced non-small cell lung cancer: A case report and literature review
por: CHEN, XUEQIN, et al.
Publicado: (2014)

Mitochondrial pathway-mediated apoptosis is associated with erlotinib-induced cytotoxicity in hepatic cells
por: Chen, Xueqin, et al.
Publicado: (2018)

MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
por: Li, Weili, et al.
Publicado: (2016)

Pemetrexed-Platinum With or Without Bevacizumab for Chinese Chemo-Naive Advanced Lung Adenocarcinoma Patients: A Real-World Study
por: Li, Xin, et al.
Publicado: (2021)

Positive Correlation of Peripheral CD8(+) T Lymphocytes with Immune-Related Adverse Events and Combinational Prognostic Value in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
por: Wu, Kan, et al.
Publicado: (2022)

The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer
por: Zhao, Dan, et al.
Publicado: (2017)

Efficacy of EGFR-TKIs with or without angiogenesis inhibitors in advanced non-small-cell lung cancer: A systematic review and meta-analysis
por: Chen, Zhaoxin, et al.
Publicado: (2020)

Are VEGFR-TKIs effective or safe for patients with advanced non-small cell lung cancer?
por: Wang, Shuai, et al.
Publicado: (2015)

Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy?
por: Zhang, Zhenyang, et al.
Publicado: (2020)

Polymorphisms of TGFBR1, TLR4 are associated with prognosis of gastric cancer in a Chinese population
por: He, Bangshun, et al.
Publicado: (2018)

VEGFR-TKIs combined with chemotherapy for advanced non-small cell lung cancer: A systematic review
por: Liu, Lian, et al.
Publicado: (2019)

ABCB1 and ABCG2 restricts the efficacy of gedatolisib (PF-05212384), a PI3K inhibitor in colorectal cancer cells
por: Liu, Changfu, et al.
Publicado: (2021)

Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis
por: Ma, Wenxia, et al.
Publicado: (2019)

Association between polymorphism in CDKN2B-AS1 gene and its interaction with smoking on the risk of lung cancer in a Chinese population
por: Lv, Xiaoting, et al.
Publicado: (2019)

Are TKIs favourable for the elderly with non-small-cell lung cancer?
por: Rossi, Sabrina, et al.
Publicado: (2016)

The role of ALDH2 and ADH1B polymorphism in alcohol consumption and stroke in Han Chinese
por: Yao, Chung-Tay, et al.
Publicado: (2011)

Management of diarrhea induced by EGFR-TKIs in advanced lung adenocarcinoma
por: Cárdenas-Fernández, Daniela, et al.
Publicado: (2023)

Prediction of the VeriStrat test in first-line therapy of pemetrexed-based regimens for advanced lung adenocarcinoma patients
por: Jia, Bo, et al.
Publicado: (2020)

CDCA4 suppresses epithelial–mesenchymal transtion (EMT) and metastasis in Non-small cell lung cancer through modulating autophagy
por: Xu, Chenxin, et al.
Publicado: (2021)

The effect of EGFR‐TKIs on survival in advanced non‐small‐cell lung cancer with EGFR mutations: A real‐world study
por: Yu, Xiaoqing, et al.
Publicado: (2022)

Single-nucleotide polymorphism rs17548629 in RIPK1 gene may be associated with lung cancer in a young and middle-aged Han Chinese population
por: Yang, Shimin, et al.
Publicado: (2020)

Benefit from Adjuvant TKIs Versus TKIs Plus Chemotherapy in EGFR-Mutant Stage III-pN2 Lung Adenocarcinoma
por: Li, Qiwen, et al.
Publicado: (2021)

Concurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer
por: Hu, Wentao, et al.
Publicado: (2017)

Association of TNFAIP8 gene polymorphisms with endometrial cancer in northern Chinese women
por: Liu, Tianbo, et al.
Publicado: (2019)

A meta-analysis of ABCG2 gene polymorphism and non-small cell lung cancer outcomes
por: Fu, Lei, et al.
Publicado: (2020)

Targeted exome sequencing identifies mutational landscape in a cohort of 1500 Chinese patients with non-small cell lung carcinoma (NSCLC)
por: Zhou, Ya-jun, et al.
Publicado: (2021)

MiR-937-3p promotes metastasis and angiogenesis and is activated by MYC in lung adenocarcinoma
por: Ma, Zijian, et al.
Publicado: (2022)

Genetic polymorphisms of estrogen receptor genes are associated with breast cancer susceptibility in Chinese women
por: Dai, Zhijun, et al.
Publicado: (2019)

The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer
por: Zhang, Jian-Wei, et al.
Publicado: (2014)

Smoking history influences the prognostic value of peripheral naïve CD4+ T cells in advanced non-small cell lung cancer
por: Liu, Chao, et al.
Publicado: (2019)

Efficacy and safety of bevacizumab combined with EGFR‐TKIs in advanced non‐small cell lung cancer: A meta‐analysis
por: Yang, Yifan, et al.
Publicado: (2021)

Outcomes of salvage lung resections in advanced EGFR ‐mutant lung adenocarcinomas under EGFR TKIs
por: Chen, Ying‐Yuan, et al.
Publicado: (2021)

Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
por: Qin, Kang, et al.
Publicado: (2020)

Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis
por: Tang, Lina, et al.
Publicado: (2018)

Optimized selection of three major EGFR-TKIs in advanced EGFR-positive non-small cell lung cancer: a network metaanalysis
por: Zhang, Yaxiong, et al.
Publicado: (2016)

Kinesin superfamily protein 21B acts as an oncogene in non-small cell lung cancer
por: Sun, Zhi-Gang, et al.
Publicado: (2020)

Interferon gamma polymorphisms and hepatitis B virus-related liver cirrhosis risk in a Chinese population
por: Sun, Yifan, et al.
Publicado: (2015)

Association between interleukin-4 gene intron 3 VNTR polymorphism and cancer risk
por: Duan, Yin, et al.
Publicado: (2014)

Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations
por: Wei, Zhigang, et al.
Publicado: (2017)

Functional polymorphisms of the lncRNA H19 promoter region contribute to the cancer risk and clinical outcomes in advanced colorectal cancer
por: Qin, Wenyan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t9i47o7hg9semumq9gb6vt5gih